Assessing public economic gains from expanding HPV vaccination in Portugal: a governmental perspective analysis

20260 citationsJournal Articlediamond Open Access

Authors

Nikolaos Kotsopoulos · National and Kapodistrian University of Athens

Mark P. Connolly · University of Groningen

Andrew Pavelyev · Merck & Co., Inc., Rahway, NJ, USA (United States)

Bernardo Rodrigues

Joana Silva

Ugne Sabale · MSD (Lithuania)

Abstract

Expanding HPV vaccination to adult populations up to 26 years of age likely offers additional economic gains that exceed expenditures when compared to the current vaccination strategy, translating public health benefits of vaccination strategies into macroeconomic and fiscal outcomes for Portugal.

Topics & Keywords

Cervical Cancer and HPV Research Vaccine Coverage and Hesitancy Virology and Viral Diseases

Publication Details

Published in: Journal of Medical Economics

Volume 29, Issue 1, pp. 282-294

DOI: 10.1080/13696998.2026.2617010

Field-Weighted Citation Impact: 0.00

Command Palette

Assessing public economic gains from expanding HPV vaccination in Portugal: a governmental perspective analysis

Authors

Abstract

Topics & Keywords

Publication Details